prostaglandin D2 antagonists (Merck & Co)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameprostaglandin D2 antagonists (Merck & Co)
Drug Alias Namelaropiprant backup compounds (Merck & Co)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin-H2 D-isomerase inhibitors
TargetsProstaglandin-H2 D-isomerase
Therapy Area/IndicationsLipid Metabolism DisordersRhinitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsLipid Metabolism DisordersRhinitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A